Butyrolactone: more than a kinase inhibitor?
- PMID: 12429918
- DOI: 10.4161/cc.1.2.114
Butyrolactone: more than a kinase inhibitor?
Comment on
-
The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression).Cell Cycle. 2002 Jan;1(1):90-6. Cell Cycle. 2002. PMID: 12429914
Similar articles
-
Proliferation arrest and induction of CDK inhibitors p21 and p27 by depleting the calcium store in cultured C6 glioma cells.Eur J Cell Biol. 1999 Nov;78(11):824-31. doi: 10.1016/S0171-9335(99)80033-8. Eur J Cell Biol. 1999. PMID: 10604659
-
The origin of CDK regulation.Nat Cell Biol. 2001 Aug;3(8):E182-4. doi: 10.1038/35087119. Nat Cell Biol. 2001. PMID: 11483974 Free PMC article. Review.
-
[Progress in the research on CDK kinase inhibitor p21Cip1].Sheng Li Ke Xue Jin Zhan. 1998 Oct;29(4):339-41. Sheng Li Ke Xue Jin Zhan. 1998. PMID: 12501664 Review. Chinese. No abstract available.
-
On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.Biochemistry. 2000 Aug 8;39(31):9494-501. doi: 10.1021/bi0009643. Biochemistry. 2000. PMID: 10924145
-
Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation.Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1002-7. doi: 10.1073/pnas.96.3.1002. Proc Natl Acad Sci U S A. 1999. PMID: 9927683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources